CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133679168
- Phone
- 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-24 | Shah Amit B. CHIEF FINANCIAL OFFICER | Purchase | +8,220 | $0.19 | $2K | 60,000 |
| 2020-11-23 | Shah Amit B. CHIEF FINANCIAL OFFICER | Purchase | +20,088 | $0.19 | $4K | 51,780 |
| 2020-11-20 | Shah Amit B. CHIEF FINANCIAL OFFICER | Purchase | +31,692 | $0.20 | $6K | 31,692 |
| 2020-11-19 | Park Chulho CHIEF TECHNOLOGY OFFICER | Purchase | +22,173 | $0.18 | $4K | 2,833,992 |
| 2020-11-19 | Trieu Vuong CHIEF EXECUTIVE OFFICER | Purchase | +50,500 | $0.19 | $10K | 15,812,308 |
| 2020-03-26 | Trieu Vuong CHIEF EXECUTIVE OFFICER | Purchase | +3,000 | $0.12 | $360 | 15,761,808 |
| 2018-06-20 | Schwieterman William D President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2018-06-20 | Schwieterman William D President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2018-06-20 | SANDAGE BOBBY W. JR., PHD. Director | Grant or award · Stock Option (Right to Buy) | +258,171 | 258,171 | ||
| 2018-06-20 | Reynolds Donald Rogers Director | Grant or award · Stock Option (Right to Buy) | +258,171 | 258,171 | ||
| 2018-06-20 | Pedder Simon Director | Grant or award · Stock Option (Right to Buy) | +258,171 | 258,171 | ||
| 2018-06-20 | LOAR MATTHEW M Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2018-06-20 | LOAR MATTHEW M Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2018-06-20 | CHAPLIN DAVID Director | Grant or award · Stock Option (Right to Buy) | +258,171 | 258,171 | ||
| 2018-04-12 | Reynolds Donald Rogers Director | Purchase | +250,000 | 280,000 | ||
| 2018-04-12 | Reynolds Donald Rogers Director | Purchase · Common Stock A Warrants (Right to Buy) | +125,000 | 125,000 | ||
| 2018-04-12 | Reynolds Donald Rogers Director | Purchase · Common Stock B Warrants (Right to Buy) | +125,000 | 125,000 | ||
| 2018-04-12 | Schwieterman William D President and CEO | Purchase | +625,000 | 625,747 | ||
| 2018-04-12 | Schwieterman William D President and CEO | Purchase · Common Stock A Warrant (Right to Buy) | +312,500 | 312,500 | ||
| 2018-04-12 | Schwieterman William D President and CEO | Purchase · Common Stock B Warrant (Right to Buy) | +312,500 | 312,500 |
Page 4 of 7 · 140 trades